SHE:300636

1 story mentioning SHE:300636Updated 51d ago

Every FINWIRES story that references SHE:300636, newest first.

Jiangxi Synergy Pharmaceutical Receives China Approval for Type 2 Diabetes Tablets

China's drug regulator approved Jiangxi Synergy Pharmaceutical's (SHE:300636) empagliflozin tablets, according to an after-hours filing on Monday with the Shenzhen bourse.Shares rose 1% during the close of trading Tuesday.The drug is indicated for type 2 diabetes patients.

SHE:300636

Track with the FINWIRES app suite

FolioX

Track SHE:300636 in your portfolio

WheelAI

Analyze SHE:300636 options with the wheel strategy

StockInsider

See market sentiment on SHE:300636